Remdesivir is an FDA approved antiviral medication used to treat Covid-19. This drug works by binding to specific viral RNA and preventing it from replicating, which reduces viral load in the body. This, in turn, helps prevent symptoms from becoming severe or requiring hospitalization, as well as improve symptoms faster.
Studies have shown that this drug can:
Remdesivir is an anti-viral medication that inhibits viral replication, which helps reduce viral load in the body. This, in turn, helps prevent symptoms from becoming severe and may help patients recover more quickly. Read More at www.covid19treatmentguidelines.nih.gov.
Remdesivir is FDA approved for use in adults and children over the age of 12. Remdesivir is also available under FDA’s emergency use authorization (FDA) in hospitalized children under the age of 12.
Like other medications, remdesivir can cause several potential symptoms, including:
IV treatments are closely monitored by our nurses to ensure patient safety during the infusion.
There are several clinical trials evaluating the use of Remdesivir for the treatment of COVID-19. Please see ClinicalTrials.gov for the latest information.
Remdesivir is available through an FDA EUA for the treatment of Covid-19 in hospitalized children under the age of 12 weighing 3.5 kg to <40 kg. There are insufficient data on the safety and efficacy of using remdesivir for COVID-19 in this population because they have not yet been evaluated in clinical trials.